Why is Pharmaids Pharma falling/rising?

As of 18-Aug, Pharmaids Pharmaceuticals Ltd is currently priced at 62.40, showing no change (0.00%). The stock's performance today is inline with the sector, although it is trading lower than the 5-day, 20-day, 100-day, and 200-day moving averages, while being higher than the 50-day moving average. Despite a notable year-to-date return of 47.00%, the stock has experienced a decline of 8.38% over the past month, indicating a recent downturn. Key negative factors include operating losses and a weak long-term fundamental strength, with a high Debt to EBITDA ratio and a significant drop in profits over the past year. These issues contribute to a perception of risk surrounding the stock, despite its historical performance.
In the broader market context, the Sensex has gained 0.83% over the past week, contrasting with Pharmaids' slight decline of 0.19% during the same period. While the stock has outperformed the market over the past year, the recent underperformance in comparison to the benchmark suggests that investor sentiment may be shifting due to the company's financial challenges. The overall market has generated negative returns of -1.14% in the last year, yet Pharmaids' strong historical returns may not be enough to offset concerns regarding its current operational difficulties and high debt levels.